ferric ammonium citrate (FAC; 100 µg/ml, 6 hrs). Endogenous p53 proteins were detected with immunoblotting using anti-p53. Actin was probed as an internal control. were used as positive controls of heme binding and lysozyme as the negative control.
The p53, ATE1, and BSA (each at 10 μM) were incubated with hemin (10 μM) in Slide-A-Lyzer Dialysis Cassettes (7K MWCO, Thermo Scientific). Dialysis of a 0.5 ml sample against 500 ml of heme binding buffer, followed by TMB assay (Pierce) to detect the remaining hemin concentrations in dialysis cassettes at indicated time points (n=3 each). (F) Gas-sensing properties of the p53-heme complex.
Ultraviolet-visible (UV-Vis) spectra analyses were carried out with p53-heme complex before (the outer blue line at the tip of the back arrow) or after nitric oxide (NO) or oxygen (O2) infusion. The red arrow indicated spectral shifts after the infusion of increasing amounts of NO. The green arrow indicated little or no shift in the spectra after O2 infusion. 
Supplemental Experimental Procedures Expression and purification of wild type and mutant p53
To express human p53 (10 µM) and its mutants bearing Cys to Ala and Pro to Ala substitutions at one or multiple Cys-Pro motifs, cDNAs encoding wild-type human p53 and the mutants were cloned into the pHUE vector to obtain the proteins with Histidine x 6 (his6)-ubiquitin (Ub) at the N-terminus and FLAG tag at the C-terminus.
The resultant plasmids were transformed into BL21 competent E. coli cells. Cells were then grown to an absorbance (OD600) of 0.8 -1.0 before addition of Isopropyl β-D-1-thiogalactopyranoside (IPTG) (final concentration of 0.3 mM). Cells were cultured at 16 °C for another 10 hours to induce expression of the recombinant p53
proteins. Proteins expressed in E. coli were purified with Nico-NTA QIA-Express protocol (Qiagen). Proteins purified at this stage were desalted on NAP-5 (GE Healthcare) to remove imidazole. Post-NAP5 protein fractions were then subjected to TMB assay or mass spectra analysis (see below). The N-terminal His6-Ub tag was removed through Usp2CC cleavage and depleted with Ni-NTA beads as previously described (Hu et al., 2005) . The supernatants were then mixed with pre-equilibrated anti-FLAG M2 beads (Sigma), followed by FLAG peptide elution according to the 
Gel filtration, spectroscopy analysis of hemin-protein complexes, and TMB assay
Purified FLAG-tagged human p53 (10 µM), its mutants that had Cys to Ala and Pro to Ala substitutions in one or multiple Cys-Pro motifs (10 µM), chicken egg white lysozyme (10 µM), or Bovine Serum Albumin (BSA) were incubated with hemin (50 µM) in binding buffer (20 mM HEPES, pH 7.4, 10% glycerol, 150 mM NaCl) for 10 mins on ice, then passed through pre-equilibrated NAP-5 columns (GE Healthcare) to remove the unbound hemin as previously described (Hu et al., 2008 Experimental iron overload was achieved by feeding 4-week-old male B6 wild-type mice a regular diet supplemented with 8.3 g/kg carbonyl iron (Sigma-Aldrich) for 3 weeks. Liver samples were weighed and iron content measured using an unsaturated iron-binding capacity assay as previously described (Ba et al., 2011) . Liver samples containing equal amounts of total protein (30 µg) were subjected to the TMB assay (Pierce) to assess hemin content. Isolation of primary hepatocytes from Hfe +/+ and Hfe -/-mice was carried out as described before (Wang et al., 2009 ). Hemin contents were measured (in triplicate) using the TMB (3,3',5,5'-tetramethyl-benzidine)-based assay (Pierce) for hepatocytes from Hfe +/+ versus Hfe -/-mouse littermates.
Preparation of hemin solution and hemin treatment of mammalian cells

Mammalian cells (including HepG2 cells, HCT116 cells and MEF cells) were adapted
to serum-free growth conditions by culture in VP-SFM (serum-free medium) (Invitrogen) as described before (Hu et al., 2008) . For cell-based experiments, hemin, freshly prepared in DMSO, was added at the indicated concentrations to 80-90% confluent cells in VP-SFM. For other experiments, stock hemin (Fe 3+ heme) solution was freshly prepared in 0.1 N NaOH for each experiment. The concentration of hemin was determined using the extinction coefficient 385 = 5.84 x 10 4 cm -1 M -1 .
Gas-sensing assay
The p53 proteins in stock solution were exchanged into the binding buffer (20 mM HEPES, 10% glycerol, 150 mM NaCl, pH 7.4) and preserved at reduced status by adding Immobilized TCEP (Tris-2'-carboxyethyl-phosphine) Disulfide Reducing Gel (Thermo Scientific). Immediately before use, the TCEP gels were pelleted to give clear p53 protein solutions. P53 proteins (10 μM) were then incubated with 50 μM hemin in binding buffer on ice for 15 mins and desalted using NAP-5 columns to remove free hemin. The solutions (0.5 ml) containing the recovered p53-hemin complexes were kept in sealed, air-tight cuvettes (VWR) on ice, followed by vacuuming and purging with argon for over 30 mins to remove residual oxygen from the solution. Dithionate (at a final concentration of 1.0 mM in binding buffer) was injected to reduce iron in hemin from a ferric to ferrous status. Balloons inflated with carbon monoxide (CO, ≥ 99.0%, from Sigma), nitric oxide (NO 98.5%, Sigma, passed through 1N KOH) or oxygen (O2, ≥ 99.6%, Sigma), were attached to the cuvettes with long needles inserted into the solutions. UV-visible spectra were recorded at 1.5 mins intervals until no more shifts were observed, indicating the maximal formation of p53-heme-gas complexes.
Surface plasmon resonanc measurements
Kinetic studies of the interactions between hemin and p53 protein were performed by measuring surface plasmon resonance (SPR) using a Biacore 3000 instrument (GE Healthcare). The p53 proteins were covalently coupled to a CM5 sensor chip (GE Healthcare) using an amine coupling kit (GE Healthcare). Stock hemin solution was freshly prepared in 0.1 N NaOH, then diluted to indicated concentrations with running buffer (20 mM HEPES, 150 mM NaCl, pH 7.8) and used as the analyte. P53-heme association was monitored for a 180 s period, while the dissociation was subsequently monitored for a 600 s period.
Mass spectrometry analysis
All mass spectra analyses were carried out on an Axima-QIT™ MALDI-Quadrupole Ion Trap-TOF (Shimadzu, Japan) to assess the presence of hemin naturally bound to recombinant human p53 or p53C275, 277A proteins. P53 or p53C275, 277A eluents from NTA-Ni columns were applied to NAP-5 column to remove imidazole. The resultant solutions (1 μl) were mixed with a matrix (1 μl) containing 4-hydroxy-α-cyanocinnamic acid (α-CHC, 10 mg/ml in 50% methanol) in 0.1% TFA (trifluoroacetic acid) (v/v). All mass spectra in this work were acquired in positive ion reflection mode after calibration with external standards. Each mass spectrum was typically collected with 150 laser spots. Mass spectra peaks at 616 Da +/-2 Da (M/Z) indicated the presence of hemin.
Hemin-agarose chromatography
HepG2 cells or HCT116 cells (p53 +/+ or p53 -/-) were grown in 100 mm dishes with DMEM containing 10% FBS. Cells were lysed in 600 µl lysis buffer (50 mM Tris, pH7.5, 10% glycerol, 1% Triton X-100, 150 mM NaCl, 10 µM NaF, 10 µM Na3VO4, 1 mM PMSF, and 1% aprotinin), then incubated with 20 µl hemin-agarose at 4 °C for 2 hrs. The beads were washed 4 times with the lysis buffer boiled in 1 X SDS-PAGE sample buffer (100 °C, 10 mins), and subjected to immunoblotting with indicated antibodies.
Luciferase reporter assay
HCT116 p53 -/-cells expressing indicated genes were seeded in 24-well plates and transfected with the luciferase reporter plasmids that contain the p53-responsive elements from the promoters of the human p21 or Bax genes. Luciferase reporter assays were carried out using a dual luciferase assay kit (Promega). Results were independently replicated in at least three experiments (each in triplicate).
Electrophoresis mobility shift assay
The electrophoresis mobility shift assay (EMSA) was performed as previously described (Jayaraman and Prives, 1995) , with slight modifications. Specifically, bovine serum albumin (BSA) was replaced with 1.5 µg/ 20 µl bovine ubiquitin, which does not bind to hemin, in the DNA-protein interaction buffer (25 mM HEPES, pH7.6, 50 mM KCl, 20% glycerol, 5 mM DTT, 5 mM MgCl2, 0.2 µg/20 µl poly (dI-dC). The double stranded DNA probes used for this EMSA contained the consensus p53 responsive element sequence (5'-AGG CAT GTC TAG GCA TGT CT -3', 5'-AGA CAT GCC TAG ACA TGC CT -3'). The probes were labeled with 32 P at the 3'-end with T4 ligase (NEB). Recombinant human p53 protein (4 µM) was then incubated with hemin at increasing concentrations (0 µM, 5 µM, 10 µM, 20 µM) on ice for 30 mins to allow for protein-hemin complex formation. The radio-labeled probe was then incubated with increasing amounts of p53 protein (0 µM, 2 µM, 4 µM) only or the above solutions containing pre-formed p53-hemin complexes. After another 30 min incubation on ice, the reaction mixtures were subjected to 6% polyacrylamide gel analysis, resolving the DNA-protein complexes from the free probes. Gels were then dried and exposed to a phosphor-imager (Kodak) before visualization on a FLA 9000
Fuji scanner.
Tryptophan fluorescence quenching assay
Fluorescence measurements were performed at room temperature (～23°C) using a Cary Eclipse spectrofluorometer (Varian, Ltd.) as described before (Hu et al., 2008) , with slight modifications. Specifically, a 280 nm excitation, three emission scans were performed (from 290 nm to 500 nm) to determine the maximal Trp-specific fluorescent emission (340 nm) of wild type p53, or p53C275, 277A (each at 1 µM).
Hemin was added to the solutions of wild type p53 protein, or p53C275, 277A to final concentrations from 0 to 18 µM. After 3 min incubations, the fluorescence intensities at 340 nm were recorded and the data were processed as previously described (Hu et al., 2008) . These analyses indicated the presence of a single hemin-binding site in wild-type p53 with Kd of ~1.21 µM. The Kd for p53C275, 277A was ~15.76 µM.
GST pull down assay
GST or GST-CRM1 proteins were purified from bacteria cells (BL21 DE3) transformed with pGEX4T-1 or pGEX4T-1-CRM1 (Wu et al., 2013) , using standard glutathione-agarose beads according to the manufacturer's instructions (GE).
His6-tagged p53 was cloned into the pET-28a vector for expression in BL21 expression strain. Purified His6-tagged human p53 (20 µM) was incubated with hemin (30 µM) in GST binding buffer (20 mM HEPES, pH 7.4, 10% glycerol, 150 mM NaCl) for 10 mins on ice, then passed through pre-equilibrated NAP-5 columns (GE Healthcare) to remove unbound hemin as described before. P53 protein or the p53-hemin complex was added to the GST binding buffer (500 µl) to a final concentration of ~8 µM . GST or GST-tagged CRM1 was added to the same concentration and mixed at 4 ºC for 2 hrs before glutathione beads were added and incubated for another 2 hrs. The protein-bound beads were then pelleted and washed 3 times with the GST binding buffer and subjected to immunoblotting analysis using anti-His or anti-GST antibodies.
Hemin-protein dialysis assay
BSA and ATE1 were used as positive controls of heme binding and lysozyme as the negative control. Purified p53 protein (10 µM), ATE1 protein (10 µM), lysozyme (10 µM), BSA (10 µM) were incubated with hemin (10 µM) in dialysis buffer (20 mM HEPES, pH 7.4, 10% glycerol, 150 mM NaCl) in Slide-A-Lyzer Dialysis Cassettes (7K MWCO, Thermo Scientific). Dialysis of a 0.5 ml sample against 500 ml of dialysis buffer was followed by a TMB assay (Pierce) to detect the remaining hemin concentrations in dialysis cassettes at indicated time points (n = 3 each).
Flow cytometry
For cell cycle analysis, HCT116 p53 +/+ or p53 -/-cells were treated with DFO (100 µM)
for 24 hrs and later supplemented with FAC (100 µg/ml, 8 hrs) and hemin (10 µM , 8 hrs) as indicated. Cells were collected and fixed in 70% ethanol overnight followed by procedures described before (Pack et al., 2008) . Fixed cells were stained with 50 μg/ml propidium iodide (PI) in the presence of RNase A (200 μg/ml) and subjected to cell cycle analysis using a FACS Calibur (BD Biosciences) flow cytomer.
Tumorigenicity assay and DFO treatment
Female nude mice (Bi-kai Biotech) aged 5-week-old were used. 1×10 6 HCT116 p53 +/+ or HCT116 p53 -/-cells were suspended in Matrigel (BD Biosciences) and injected s.c. into the mice according to standard procedures. Mice bearing evident tumors were randomly divided into control and DFO treatment groups (four mice per group). DFO was dissolved in water and injected into tumors at a dose of 500 mg/kg/d over 6 consecutive days. After animals were euthanized with carbon dioxide, tumor masses were isolated and tumor weight measured.
Ubiquitylation assays
HepG2 cells transfected with His6-tagged ubiquitin plasmids were treated with hemin (10 µM), MG132 (10 µM), or both for 6 hrs. Cells were lysed in modified RIPA buffer [50 mM Tris-Cl, pH7.4, 150 mM NaCl, 5 mM EDTA, 1% (v/v) Triton X-100, 0.5% sodium pyrophosphate, 0.1% SDS, and protease inhibitor cocktail (Roche)]. IP experiments were also carried out in modified RIPA buffer using anti-p53 and followed by immunoblotting with anti-His antibodies (Lee et al., 2008) .
Fluorescence and immunofluorescence microscopy
Cells were seeded on gelatin-coated coverslips in 6-well plates, transfected with the indicated plasmids, and received any indicated treatments. Afterwards, cells were washed in phosphate-buffered saline (PBS) before fixation in 2% formaldehyde. Cells were subject to 4'-6-Diamidino-2-phenylindole (DAPI) staining to visualize cell nuclui and the green fluorescent protein (GFP) was directly visualized.
Immunofluorescence microscopy analyses with indicated antibodies were carried out as described before (Shen et al., 2011) . Immunofluorescence was visualized and recorded on a Olympus BX51 microscope and Leica TCS SP2 laser confocal microscope. Images were processed using Leica LAS-AF software and Adobe Photoshop CS3.
Multiple sequence alignments and PDB coordinates
Proteins sequence alignments were performed with Clustal X v2.0 according to the provider's instructions (Larkin et al., 2007) . PDB coordinates of the p53-DNA complex were extracted from the Protein Data Bank (pdb ID 1TSR) (Cho et al., 1994) and visualized on PyMOL (DeLano Scientific LLC, San Carlos, CA, USA).
Statistical analysis
All values are expressed as means ± SEM. The two tailed unpaired Student's t-test was used to assess the significance of differences between two sets of data.
Differences were considered to be statistically significant when P < 0.05.
